Clinical Trials on Esophagus Cancer, Adenocarcinoma in New Zealand

Total 8508 results

University of Colorado, Denver

Recruiting

Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance (SWAT-BE)

Barrett Esophagus | Esophageal Adenocarcinoma | Barretts Esophagus With Dysplasia

United States
National Cancer Institute (NCI)

Completed

Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer

Adenocarcinoma of the Gastroesophageal Junction | Squamous Cell Carcinoma of the Esophagus | Adenocarcinoma of the Esophagus | Recurrent Esophageal Cancer | Stage IV Esophageal Cancer | Stage III Esophageal Cancer

United States
Mayo Clinic

Recruiting

Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples (SOS4C)

Barrett Esophagus | Esophageal Adenocarcinoma | Barrett's Esophagus Without Dysplasia | Barretts Esophagus With Dysplasia

United States
National Cancer Institute (NCI)

Terminated

A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer

Adenocarcinoma of the Gastroesophageal Junction | Stage IV Gastric Cancer | Recurrent Gastric Cancer | Squamous Cell Carcinoma of the Esophagus | Adenocarcinoma of the Esophagus | Recurrent Esophageal Cancer | Stage IV Esophageal Cancer | Diffuse Adenocarcinoma of the Stomach | Intestinal Adenocarcinoma... and other conditions

United States
Columbia University
Mayo Clinic; University of Pennsylvania

Completed

The Microenvironment in Barrett's Esophagus (BETRNet2)

Barrett Esophagus | Esophageal Adenocarcinoma

United States
The Guthrie Clinic

Terminated

Surveillance of Patients With Adenocarcinoma of the Gastroesophageal Junction or Esophagus (SAGE)

Adenocarcinoma Esophagus

United States
Lucid Diagnostics, Inc.

Completed

Efficacy of EsoGuard on Samples Collected Using EsoCheck Versus EGD for the Diagnosis of BE (ESOGUARDBE1)

Barrett Esophagus | Esophageal Adenocarcinoma | Barrett's Esophagus Without Dysplasia | Barretts Esophagus With Dysplasia

United States, Spain
ABK Biomedical

Completed

Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable HCC and mCRC

Metastatic Colorectal Cancer | Liver Cancer | Hepatocellular Carcinoma Non-resectable

New Zealand
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb

Completed

A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer

Gastric Cancer | Esophageal Cancer | Gastric Adenocarcinoma | Esophagogastric Cancer | Gastroesophageal Junction Adenocarcinoma | Esophagus Cancer | Gastroesophageal Junction Squamous Cell Carcinoma

United States
Roswell Park Cancer Institute

Completed

Study To Determine The Maximum Range of Light Doses At Two HPPH Doses With Acceptable Normal Tissue Toxicity For PDT Treatment Of High Grade Dysplasia,CIS or Early Adenocarcinoma In Barrett's Esophagus

Barrett's Esophagus | CIS | HGD

United States
Columbia University
National Cancer Institute (NCI); Weill Medical College of Cornell University

Recruiting

The Microbiome, Bile Acids, and Notch in Barrett's Esophagus (BE)

Barrett Esophagus | Esophageal Adenocarcinoma

United States
Columbia University

Suspended

Rapid Assessment of Esophageal Adenocarcinoma Risk Test (REACT)

Barrett Esophagus | Esophageal Adenocarcinoma

United States
Johns Hopkins University
American Society for Gastrointestinal Endoscopy; Pentax Medical Corporation

Completed

Confocal Endomicroscopy for Improved Diagnosis of Barrett's Esophagus and Early Esophageal Cancer(CEBE Study) (CEBE)

Barrett's Esophagus, Esophageal Intraepithelial Neoplasia

United States, Germany
Lucid Diagnostics, Inc.

Recruiting

Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC (ESOGUARDBE2)

Barrett Esophagus | Esophageal Adenocarcinoma | Barrett's Esophagus Without Dysplasia | Barretts Esophagus With Dysplasia

United States, Netherlands
Mayo Clinic

Recruiting

Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma

Barrett Esophagus | Esophageal Adenocarcinoma

United States
Columbia University

Completed

Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome (Mouthwash)

Barrett's Esophagus | Esophageal Adenocarcinoma | Reflux Esophagitis

United States
Pentax Medical

Completed

Evaluation of Balloon-based Cryoablation of Human Esophageal Epithelium

Esophageal Cancer | Barrett's Esophagus

United States, Netherlands
Northwell Health

Terminated

In Vivo Anatomy, Physiology, Mechanics and Function of the Lower Esophageal Sphincter

GERD | Barretts Esophagus

United States
Professor Michael Bourke

Withdrawn

Long Term Barrett's Endoscopic Mucosal Resection Study (CBE)

Barretts Esophagus

Australia
Northwell Health
Mayo Clinic; NinePoint Medical

Completed

Volumetric Laser Endomicroscopy With Intelligent Real-time Image Segmentation (IRIS)

Barrett's Esophagus Without Dysplasia | Barrett's Esophagus With Dysplasia | Barrett's Esophagus With Low Grade Dysplasia | Barrett's Esophagus With High Grade Dysplasia | Barrett's Esophagus With Dysplasia, Unspecified

United States
Mauna Kea Technologies
Emissary International LLC; Cellvizio Inc.

Completed

Detection Of Neoplastic Tissue in Barrett's Esophagus With In vivO Probe-based Confocal Endomicroscopy (DONTBIOPCE)

Adenocarcinoma | Barrett's Esophagus | Barrett Esophagus | Barrett Syndrome | Barrett's Syndrome

United States, France, Germany
University of Auckland, New Zealand

Completed

Profiling of Oncology Patients as Part of Clinical Care and Research (PROSPER)

Gynecologic Cancer

New Zealand
Mayo Clinic

Completed

Characterization of the Neo-squamous Epithelial Barrier

Barrett's Esophagus With Dysplasia

United States
Erbe Elektromedizin GmbH
NAMSA; Kansas City Veteran Affairs Medical Center; Erbe USA Incorporated

Terminated

Eradicating Barrett's Esophagus Using Radiofrequency Ablation or a Novel Hybrid Argon Plasma Coagulation Technique (BURN)

Barrett's Esophagus | High-grade Dysplasia in Barrett Esophagus | Low Grade Dysplasia in Barrett Esophagus

United States
Auckland District Health Board
Novartis; University of Auckland, New Zealand; IGENZ, Ltd., Auckland

Unknown

1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC (DILIGENCE-1)

Clear Cell Renal Cell Carcinoma

New Zealand
Anandasabapathy, Sharmila, M.D.
Icahn School of Medicine at Mount Sinai

Completed

Evaluation of a Miniaturized Microscope Device for the Detection of Barrett's Neoplasia: A Pilot Study

Barrett's Esophagus

United States
Professor Michael Bourke

Recruiting

Australian Barrett's Cohort With Dysplasia and Early Cancer Study (ABCDE)

Barrett's Esophagus

Australia
Anandasabapathy, Sharmila, M.D.

Terminated

A Feasibility Study of Confocal Microendoscopy in the Evaluation of Gastrointestinal Neoplasia -Project 1

GERD | Barrett's Esophagus

United States
Lucid Diagnostics, Inc.
Medex15

Recruiting

Clinical Utility of a Non Endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barrett's Esophagus in At Risk Population (ASBE)

Barrett Esophagus

United States
Hoffmann-La Roche

Completed

A Dose-Finding Study of Pertuzumab (Perjeta) in Combination With Trastuzumab (Herceptin) in Healthy Male Participants and Women With Early Breast Cancer (EBC)

Early Breast Cancer

New Zealand
Interscope, Inc.

Recruiting

Endorotor Resection In Refractory Barrett's Dysplasia Patients

Barrett's Esophagus With Dysplasia

United States, Sweden, United Kingdom
Columbia University
National Cancer Institute (NCI); University of Michigan

Recruiting

Longitudinal Oral Microbiome Sampling for BE

Barrett Esophagus

United States
Virendra Joshi

Completed

Confocal Laser Probe to Treat Barrett's Esophagus (pCLE)

Barrett's Esophagus

United States
Australasian Gastro-Intestinal Trials Group
University of Sydney

Active, not recruiting

The ASCEND Study: Gemcitabine and Nab-Paclitaxel With CEND-1/LSTA1 or Placebo in Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma (ASCEND)

Pancreatic Ductal Adenocarcinoma | Metastatic Pancreatic Cancer

Australia, New Zealand
Columbia University
Trio Medicines Ltd.

Completed

Trial of a Gastrin Receptor Antagonist in Barrett's Esophagus

Barrett's Esophagus

United States, United Kingdom
Keythera Pharmaceuticals (Australia) Pty Ltd

Recruiting

A Study of KF-0210 in Advanced Solid Tumors Patients

Gastric Cancer | Colorectal Cancer | Lung Cancer | Bladder Cancer | Advanced Solid Tumor | Squamous Cell Carcinoma of the Esophagus

Australia
Trio Medicines Ltd.
Columbia University; University of Cambridge

Completed

YF476 in Barrett's Esophagus

Barrett's Esophagus

United States, United Kingdom
Roswell Park Cancer Institute

Completed

Study of Photodynamic Therapy (PDT) Using HPPH in Barrett's Esophagus

Barrett's Esophagus | CIS | High Grade Dysplasia

United States
Anandasabapathy, Sharmila, M.D.
William Marsh Rice University

Completed

Endoscopic Multispectral Imaging for the Early Detection of Barrett's Neoplasia

Barrett's Esophagus | Intraepithelial Neoplasia

United States
Case Western Reserve University
Johns Hopkins University; Mayo Clinic; University of Pennsylvania; Washington University... and other collaborators

Recruiting

Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma (FBE)

Barrett's Esophagus | Esophageal Neoplasm

United States
Trans Tasman Radiation Oncology Group
Fisher and Paykel Healthcare; Auckland City Hospital

Completed

Radiotherapy With Humidification in Head And Neck Cancer (RadioHum)

Cancer of the Head and Neck

New Zealand
Mayo Clinic
National Cancer Institute (NCI)

Completed

Betrnet Stem Cells and the Origins of Barrett's Esophagus Project 3 RF Ablation (BetrnetRF)

Barrett's Esophagus

United States
National Cancer Institute (NCI)

Completed

Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients With Barrett's Esophagus

Barrett Esophagus

United States
Professor Michael Bourke

Withdrawn

Barretts oEsophageal Resection With Steroid Therapy Trial (BERST)

Barrett Esophagus | Esophageal Stenosis

Australia
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)

Completed

Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus

Esophageal Cancer

United States
Middlemore Hospital, New Zealand

Unknown

Comparing Diagnostic Yield Between R-EBUS Guided Cryo Biopsy Vs. CT Guided Biopsy for PPL (CT-CROP)

Lung Cancer

New Zealand
Massachusetts General Hospital
National Cancer Institute (NCI); Mayo Clinic; Columbia University; National Institutes... and other collaborators

Active, not recruiting

Coordinating Center: Natural History of Barrett's Esophagus Using Tethered Capsule Endomicroscopy

Barrett Esophagus

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus

Esophageal Cancer

United States
Pentax Medical

Completed

Evaluation of Effect of CryoBalloon Focal Ablation System on Human Esophageal Barrett's Epithelium

Barrett's Esophagus

United States, Netherlands
Memorial Sloan Kettering Cancer Center

Recruiting

Retrospective Review of Esophageal Cancer at MSKCC

Esophageal Cancer | Esophagus Cancer

United States

Clinical Trials on Esophagus Cancer, Adenocarcinoma in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations